ロード中...

Nonmitogenic Anti-CD3 Monoclonal Antibodies Deliver a Partial T Cell Receptor Signal and Induce Clonal Anergy

Anti-CD3 monoclonal antibodies (mAbs) are potent immunosuppressive agents used in clinical transplantation. However, the activation-related adverse side effects associated with these mAbs have prompted the development of less toxic nonmitogenic anti-CD3 mAb therapies. At present, the functional and...

詳細記述

保存先:
書誌詳細
主要な著者: Smith, Judith A., Tso, J. Yun, Clark, Marcus R., Cole, Michael S., Bluestone, Jeffrey A.
フォーマット: Artigo
言語:Inglês
出版事項: The Rockefeller University Press 1997
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2196281/
https://ncbi.nlm.nih.gov/pubmed/9126922
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!